» Articles » PMID: 35564876

Proposing a "Brain Health Checkup (BHC)" As a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis"

Overview
Publisher MDPI
Date 2022 May 14
PMID 35564876
Authors
Affiliations
Soon will be listed here.
Abstract

In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric and cognitive impairments are underreported comorbidities of reward dysregulation due to genetic antecedents and epigenetic insults. Recent genome-wide association studies involving millions of subjects revealed frequent comorbidity with substance use disorder (SUD) in a sizeable meta-analysis of depression. It found significant associations with the expression of NEGR1 in the hypothalamus and DRD2 in the nucleus accumbens, among others. However, despite the rise in SUD and neuropsychiatric illness, there are currently no standard objective brain assessments being performed on a routine basis. The rationale for encouraging a standard objective Brain Health Check (BHC) is to have extensive data available to treat clinical syndromes in psychiatric patients. The BHC would consist of a group of reliable, accurate, cost-effective, objective assessments involving the following domains: Memory, Attention, Neuropsychiatry, and Neurological Imaging. Utilizing primarily PUBMED, over 36 years of virtually all the computerized and written-based assessments of Memory, Attention, Psychiatric, and Neurological imaging were reviewed, and the following assessments are recommended for use in the BHC: Central Nervous System Vital Signs (Memory), Test of Variables of Attention (Attention), Millon Clinical Multiaxial Inventory III (Neuropsychiatric), and Quantitative Electroencephalogram/P300/Evoked Potential (Neurological Imaging). Finally, we suggest continuing research into incorporating a new standard BHC coupled with qEEG/P300/Evoked Potentials and genetically guided precision induction of "dopamine homeostasis" to diagnose and treat reward dysregulation to prevent the consequences of dopamine dysregulation from being epigenetically passed on to generations of our children.

Citing Articles

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.

Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B J Addict Psychiatry. 2024; 8(1):50-95.

PMID: 39635461 PMC: 11615735.


Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.

Blum K, Braverman E, Gold M, Dennen C, Baron D, Thanos P INNOSC Theranostics Pharmacol Sci. 2024; 7(2):1472.

PMID: 38766548 PMC: 11100020. DOI: 10.36922/itps.1472.


Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.

Blum K, Baron D, Mclaughlin T, Thanos P, Dennen C, Ceccanti M J Addict Psychiatry. 2024; 8(1):1-33.

PMID: 38765881 PMC: 11100022.


Are We Getting High Cause the Thrill is Gone?.

Blum K, Mclaughlin T, Gold M, Gondre-Lewis M, Thanos P, Elman I J Addict Psychiatry. 2024; 7(1):5-516.

PMID: 38164471 PMC: 10758019.


Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?.

Blum K, Bowirrat A, Braverman E, Dennen C, Zeine F, Jafari N Clin Exp Psychol. 2023; 9(2):1-3.

PMID: 37363693 PMC: 10288571.


References
1.
Kandel D, Kandel E . The Gateway Hypothesis of substance abuse: developmental, biological and societal perspectives. Acta Paediatr. 2014; 104(2):130-7. DOI: 10.1111/apa.12851. View

2.
Irving H, Samokhvalov A, Rehm J . Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009; 10(4):387-92. PMC: 3299482. View

3.
Filbey F, McQueeny T, DeWitt S, Mishra V . Preliminary findings demonstrating latent effects of early adolescent marijuana use onset on cortical architecture. Dev Cogn Neurosci. 2015; 16:16-22. PMC: 4691364. DOI: 10.1016/j.dcn.2015.10.001. View

4.
Muller M, Grobbee D, Tonkelaar I, Lamberts S, van der Schouw Y . Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005; 90(5):2618-23. DOI: 10.1210/jc.2004-1158. View

5.
Blum K, Thompson B, Demotrovics Z, Femino J, Giordano J, Oscar-Berman M . The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. J Reward Defic Syndr. 2015; 1(1):46-64. PMC: 4545669. DOI: 10.17756/jrds.2015-008. View